Marshall Wace North America’s PetMed Express PETS Stock Holding History

Marshall Wace North America’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-24,450	Closed	-$784K	–	1708
2020 Q4	$784K	Buy	+24,450	New	+$754K	﹤0.01%	995
2019 Q2	–	Sell	-41,629	Closed	-$947K	–	1504
2019 Q1	$947K	Buy	41,629 +11,522	+38%	+$260K	0.01%	678
2018 Q4	$700K	Buy	+30,107	New	+$804K	0.01%	696
2018 Q3	–	Sell	-35,968	Closed	-$1.58M	–	1260
2018 Q2	$1.58M	Sell	35,968 -256,816	-88%	-$9.94M	0.01%	828
2018 Q1	$12.2M	Buy	292,784 +215,675	+280%	+$9.96M	0.06%	348
2017 Q4	$3.51M	Buy	77,109 +32,705	+74%	+$1.29M	0.02%	682
2017 Q3	$1.47M	Buy	+44,404	New	+$1.81M	0.01%	867
2017 Q2	–	Sell	-48,470	Closed	-$969K	–	1421
2017 Q1	$969K	Buy	+48,470	New	+$1.03M	0.01%	708
2013 Q4	–	Sell	-29,852	Closed	-$486K	–	809
2013 Q3	$486K	Buy	+29,852	New	+$466K	0.01%	450

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Marshall Wace North America's PETS Position: Q1 2021 in Review

Marshall Wace North America sold out of PetMed Express (PETS) in Q1 2021, closing a stake of 24,450 shares — an estimated $784K sold.

Marshall Wace North America first reported a position in PETS in Q3 2013 and held it in 9 quarters. The position peaked at $12.2M in Q1 2018. 205 funds tracked by Wall St. Rank hold PETS as of Q1 2021.

Marshall Wace North America reported no remaining PetMed Express position as of Q1 2021 after selling out during the quarter.
Marshall Wace North America sold 24,450 PetMed Express shares in Q1 2021, an estimated $784K.
Marshall Wace North America first reported a position in PetMed Express in Q3 2013 and held it in 9 quarters.
Marshall Wace North America's PetMed Express position peaked at $12.2M in Q1 2018.
205 funds tracked by Wall St. Rank held PetMed Express as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.